2019 Novel Coronavirus

Download Document

APBN Rapid Brief White Paper 2019 Novel Coronavirus (SARS-CoV-2); Expected challenges and risks to blood safety

The 2019 Novel Coronavirus (SARS-CoV-2) which emerged in China presents a significant health threat in the Asia-Pacific region, and the ability to impact blood supply through donor deferrals, illness, quarantine and reduced staff or donor availability.

This paper outlines key challenges and risks to assist blood sector preparedness, response and implementation of appropriate risk reduction strategies.